Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Lymphatic Metastasis 2Breast Neoplasms 2

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
gadofosveset trisodium × Breast × Clear all
NCT01609920 2016-11-10

Nodal Staging in Breast Cancer With MRL

Maastricht University Medical Center

Phase NA Terminated
97 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT01437865 2012-04-06

Gadofosveset for Axillary Staging in Breast Cancer Patients

Maastricht University Medical Center

Phase NA Completed
10 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡